Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in pfizer

Pfizer To Extend Covid Vaccine Contract With EU To 2026

The drugmaker has offered to cut the number of doses being supplied by 40 per cent and delay delivery of the shots, the report added. Under the revised terms, Pfizer is asking for payment for doses ordered that will never be manufactured, the FT report said

Read More

Pfizer Agrees To Buy Seagen For $43 Bn

The agreement is an early sign that, despite the threat of close antitrust examinations and higher interest rates, big pharmaceutical companies are poised for heavy deal-making this year

Read More

Pfizer/Biontech, Moderna Prepare For London Trial 2024

Pfizer and BioNTech sued Moderna in London in September, seeking to revoke two of Moderna's patents in relation to its messenger RNA (mRNA) vaccines.

Read More

Pfizer Predicts Weak 2023 Sales Of Covid Products

The U.S. drugmaker said it expects sales of USD 13.5 billion from the vaccine for 2023, below Refinitiv estimates of USD 14.39 billion, and projected USD 8 billion in sales of its antiviral pill, Paxlovid, short of analysts' expectation of USD 10.33 billion

Read More

No Covid Test Requirements For Pfizer, Merck Pills: USFDA

The health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result

Read More

Pfizer CEO Runs Away From Vaccine Questions In Davos

Back in the early days of the vaccination campaign, the US-based pharmaceutical company Pfizer sought an indemnity bond to protect it from legal claims if the vaccine caused any adverse effects

Read More

Pfizer To Sell All Its Drugs At Non-profit Price In Low-income Countries

n an expansion of the company's "An Accord for a Healthier World" program, which is aimed at increasing access to innovative treatments in some of the world's poorest countries, Pfizer said it will now offer a total of 500 products

Read More

Pfizer's Covid Drug Paxlovid Difficult To Get In China

Chinese authorities have acknowledged that supplies of Paxlovid are still insufficient to meet demand, even as Pfizer CEO Albert Bourla said last week that thousands of courses of the treatment were shipped to the country last year and in the past couple of weeks millions more were shipped

Read More

Pfizer To Explore Options Regarding Rare Disease, Cancer Drugs

Pfizer now plans to focus on internally developing rare disease treatments using technologies such as gene editing, it said, while exploring external opportunities for early-stage gene therapy programs and its cancer-focused research facility in Boulder, Colorado

Read More

Pfizer's Hemophilia B Gene Therapy Pass The Late-Stage Study

Pfizer's therapy, fidanacogene elaparvovec, is designed to help patients produce factor IX themselves after a one-time treatment, as opposed to current treatments, which focus on regular infusions of the protein

Read More

Pfizer Wins Race-bias Lawsuit On Minority Fellowship Program

The lawsuit was filed in September, a month before the U.S. Supreme Court heard arguments in a pair of cases against Harvard University and the University of North Carolina that could determine the future of affirmative action in higher education

Read More

Pfizer's Annual Revenue To Touch $10 Bn-$15 Bn Sourced From mRNA Vaccines By 2030

The company's revenue is expected to top $100 billion this year- more than double the pre-pandemic level - helped by strong demand for its COVID-19 vaccine and oral treatment Paxlovid

Read More

GSK, Pfizer, Sanofi Evade Federal Litigation On Zantac

The ruling by U.S. District Judge Robin Rosenberg in West Palm Beach, Florida, knocks out about 50,000 claims in federal court, though it does not affect tens of thousands of similar cases pending in state courts around the country

Read More

Biontech, Pfizer Countersue Moderna On Vaccine Patents

Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany. All three companies are also embroiled in U.S. patent disputes with other companies over the vaccines

Read More

Above $2.5 Bln Pfizer Investment To Expand European Manufacturing

The drugmaker said on Friday it plans to spend more than 1.2 billion euros (USD 1.26 billion) to expand its Puurs, Belgium, manufacturing site, matching the investment at its Dublin, Ireland, plant announced on Thursday

Read More